MedPath

Efficacy of Pathyadi Varti Anjanaand Eye Exercise in Timira - Simple Myopia

Phase 2/3
Completed
Conditions
Myopia,
Registration Number
CTRI/2020/03/024161
Lead Sponsor
All India Institute of Ayurveda
Brief Summary

Simple myopia is an important health issue in India with high incidence and progression. This condition comes under the purview of “TImira†in Ayurveda. Ocular health can be maintained and promoted by existing treatment modalities in Ayurveda. The management can be fastened if those are supplemented by some ocular strengthening therapy. Approach of Ayurveda may certainly provide good results in myopia by judiciously planning the ocular treatment along with eye exercises. This study is an attempt to evaluate the efficacy of Pathyadi Varti (Ayurveda drug) in the form of Anjana (Collyrium) alone and along with eye exercise in Timira with special reference to simple myopia.

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Sign and Symptoms showing Prathama and Dwithiya Patalagata Timira 2.
  • Functional Refractive errors in Myopia upto 6.0 D 3.
  • Patients fit for Anjana
.
Exclusion Criteria
  • Patients not willing to participate in the study.
  • Patients having other systemic disease or metabolic disorders such as hypertension, diabetic mellitus and thyroid and any other illness.
  • Patients having any lenticular or Corneal opacity and any other known ocular pathology such as optic atrophy, diabetic retinopathy and hypertensive retinopathy.
  • History of any surgical intervention to eye.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in symptoms and 0.5D improvement in clinical refraction.21 day, 42 day
Secondary Outcome Measures
NameTimeMethod
Improvement in unaided visual acuity21 day, 42 day

Trial Locations

Locations (1)

All India Institute of Ayurveda

🇮🇳

Delhi, DELHI, India

All India Institute of Ayurveda
🇮🇳Delhi, DELHI, India
Dr Deenadayal Devarajan
Principal investigator
8848733503
drdayal1034@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.